Literature DB >> 19553403

Propofol clearance and volume of distribution are increased in patients with major burns.

Tae-Hyung Han1, David J Greenblatt, J A Jeevendra Martyn.   

Abstract

Propofol pharmacokinetics were examined in 17 adults with major burns during the hyperdynamic convalescent phase. Eighteen nonburned surgical patients served as controls. After a 2-mg/kg intravenous dose of propofol, blood samples were collected at multiple time points. Noncompartmental methods were used to calculate the pharmacokinetic parameters. The following indices were higher in burns than controls: propofol clearance (64+/-17 vs 29+/-4 mL/kg/min, P<.001) and volume of distribution (8+/-3 vs 4+/-1 L/kg, P<.001). The area under the curve was smaller in burns (556+/-152 vs 1193+/-183 microg/mL h, P<.001). The higher clearance of propofol in burned patients may imply that these patients require higher doses or infusion rates of propofol to attain a target plasma concentration or pharmacodynamic effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553403     DOI: 10.1177/0091270009335767

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  3 in total

1.  Performance evaluation of a whole blood propofol analyser.

Authors:  Bo Liu; David M Pettigrew; Stephen Bates; Peter G Laitenberger; Gavin Troughton
Journal:  J Clin Monit Comput       Date:  2012-01-01       Impact factor: 2.502

Review 2.  Acute and perioperative care of the burn-injured patient.

Authors:  Edward A Bittner; Erik Shank; Lee Woodson; J A Jeevendra Martyn
Journal:  Anesthesiology       Date:  2015-02       Impact factor: 7.892

3.  GTS-21 attenuates loss of body mass, muscle mass, and function in rats having systemic inflammation with and without disuse atrophy.

Authors:  Stefan J Schaller; Michio Nagashima; Martin Schönfelder; Tomoki Sasakawa; Fabian Schulz; Mohammed A S Khan; William R Kem; Gerhard Schneider; Jürgen Schlegel; Heidrun Lewald; Manfred Blobner; J A Jeevendra Martyn
Journal:  Pflugers Arch       Date:  2018-07-13       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.